Search results for: 'partnering agreements with the medicine companion 2025 2025'
- Related search terms
- Partnering Merger and
- companion diagnostic partnering terms report
- companion diagnostics partnering term and agreements 3rd edison
- partnering agreements with the medicine compani 2023 2023
- partnering agreements with busi 2016 2023
-
Drug Delivery Collaboration and Licensing Deals 2019-2025May 2025$3,995.00Drug Delivery Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Licensing Deals in Pharmaceuticals 2019-2025September 2025$4,995.00Licensing Deals in Pharmaceuticals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010 to 2025September 2025$4,995.00Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2025 | 15+ years of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More -
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025September 2025$3,995.00Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Distribution Deals in Pharmaceuticals and Biotechnology 2020 to 2025September 2025$3,995.00Distribution Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Merger and Acquisition (M&A) Deals in Pharmaceuticals, Biotechnology and Diagnostics 2020-2025August 2025$3,995.00Global coverage | Deal financials | Contract documents | Deal trends | Leading M&A dealmakers | Comprehensive deal directory 2020 to 2025
Learn More -
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025September 2025$3,995.00Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019 to 2025September 2025$3,995.00Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2019 to 2025
Learn More -
Genomic Collaboration and Licensing Deals 2018-2025May 2025$3,995.00Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2025May 2025$3,995.00Cancer Monoclonal Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More
- Category CP Reports Store Remove This Item
